Met Life Investment Management, LLC Amylyx Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.71 - $19.57 $37,311 - $269,439	13,768 New	13,768 $39,000
Q2 2023 Apr 29, 2024	BUY	$20.98 - $31.42 $560,417 - $839,291	26,712 New	26,712 $576,000
Q1 2023 May 09, 2024	BUY	$27.71 - $40.93 $740,189 - $1.09 Million	26,712 New	26,712 $784 Million
Q4 2022 May 10, 2024	BUY	$29.75 - $39.26 $215,717 - $284,674	7,251 Added 37.26%	26,712 $987,000
Q4 2022 Mar 22, 2023	BUY	$29.75 - $39.26 $215,717 - $284,674	7,251 Added 37.26%	26,712 $987,000
Q4 2022 Feb 15, 2023	BUY	$29.75 - $39.26 $215,717 - $284,674	7,251 Added 37.26%	26,712 $987,000
Q3 2022 May 10, 2024	BUY	$17.15 - $30.92 $217,393 - $391,941	12,676 Added 186.82%	19,461 $542,000
Q3 2022 Jun 14, 2023	SELL	$17.15 - $30.92 $124,354 - $224,200	-7,251 Reduced 27.15%	19,461 $542,000
Q3 2022 Mar 22, 2023	BUY	$17.15 - $30.92 $217,393 - $391,941	12,676 Added 186.82%	19,461 $542,000
Q3 2022 Nov 14, 2022	BUY	$17.15 - $30.92 $217,393 - $391,941	12,676 Added 186.82%	19,461 $548,000
Q2 2022 Jun 20, 2023	SELL	$6.85 - $19.93 $136,499 - $397,145	-19,927 Reduced 74.6%	6,785 $130,000
Q1 2022 May 10, 2024	BUY	$12.85 - $32.9 $87,187 - $223,226	6,785 New	6,785 $87,000
Q1 2022 Jun 20, 2023	SELL	$12.85 - $32.9 $256,061 - $655,598	-19,927 Reduced 74.6%	6,785 $87,000
Q1 2022 Mar 22, 2023	SELL	$12.85 - $32.9 $256,061 - $655,598	-19,927 Reduced 74.6%	6,785 $87,000
Q1 2022 May 12, 2022	BUY	$12.85 - $32.9 $87,187 - $223,226	6,785 New	6,785 $87,000

142

45.3M

235K

498K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $212M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.